AEPCX | HNCCX | AEPCX / HNCCX | |
Total Expense Ratio | 1.57 | 2.05 | 77% |
Annual Report Gross Expense Ratio | 1.57 | 2.14 | 73% |
Fund Existence | 25 years | 24 years | - |
Gain YTD | 15.038 | 18.812 | 80% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2000 | 13% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 133B | 342M | 38,889% |
Annual Yield % from dividends | 0.16 | 0.00 | - |
Returns for 1 year | 7.59 | 18.73 | 41% |
Returns for 3 years | 32.65 | 60.14 | 54% |
Returns for 5 years | 7.78 | 22.28 | 35% |
Returns for 10 years | 34.34 | 64.33 | 53% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETNHX | 39.57 | 0.50 | +1.28% |
Eventide Healthcare & Life Sciences N | |||
CGFAX | 84.69 | 0.20 | +0.24% |
American Funds Growth Fund of Amer 529A | |||
FRAAX | 60.81 | N/A | N/A |
Franklin Growth Opportunities Adv | |||
DNLDX | 64.61 | -0.01 | -0.02% |
BNY Mellon Active MidCap A | |||
MIIOX | 30.51 | -0.02 | -0.07% |
Marsico International Opportunities Inst |